Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Recruiting · NCT06373458 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Recruiting | Phase 2 | 2026-09-01 | NCT06373458 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 256 |
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |